Skip to main content

Advertisement

SpringerLink
Log in

A systematic review of pharmacokinetics studies in children with protein-energy malnutrition

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

Protein energy malnutrition (PEM) is a nutritional problem affecting many children world-wide. Its association with a wide spectrum of infections necessitates multiple drug therapies. A systematic review was performed to determine the effects of PEM on drug pharmacokinetics.

Methods

Literature searches in the MEDLINE and EMBASE databases (January 1960 to December 2009) were performed. Malnutrition, undernutrition, underweight, protein-energy malnutrition, protein-calorie malnutrition, marasmus, marasmic-kwashiorkor or kwashiorkor was the medical subject heading (MeSH) descriptor used. Inclusion criteria were abstracts that assessed or discussed absorption, distribution, metabolism, elimination, clearance, pharmacokinetics or pharmacodynamics of drugs, except micronutrients and appetite-stimulating drugs.

Results

Altogether, 41 publications were identified. A total of 34 drugs were studied. The absorption of 18 drugs was studied; the extent of absorption (AUC) was unaffected for 10 drugs. The plasma protein binding of 20 drugs was evaluated; it was significantly reduced for 12 drugs. The volume of distribution (Vd) of 13 drugs was evaluated; it was, however, unaffected for most of the drugs. The effect of PEM on total clearance and the half-life of drugs primarily metabolised by the liver was studied for 8 drugs. There was decreased total clearance and an associated increased half-life of 5 drugs. For 2 drugs (chloramphenicol and quinine), different degrees of PEM affected total clearance differently. The total clearance of six drugs primarily eliminated by the kidneys was studied; it was unaffected for four drugs, but significantly decreased for two drugs (cefoxitin and penicillin).

Conclusions

Considering the proportion of children affected with PEM world-wide, there have been relatively few pharmacokinetic studies of drugs frequently used for their treatment. More studies are therefore required to establish the appropriate dose and safety of these drugs for PEM children. The studies need to recognise that PEM is a disease spectrum and should further look at the differential effects of kwashiorkor and marasmus on drug pharmacokinetics in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Collins S, Dent N, Binns P, Bahwere P, Sadler K, Hallam A (2006) Management of severe acute malnutrition. Lancet 368:1992–2000

    Article  PubMed  Google Scholar 

  2. Nnakwe N (1995) The effect and causes protein-energy malnutrition in Nigerian children. Nutr Res 15:785–794

    Article  Google Scholar 

  3. World Health Organization (2005) Nutrition: challenges. Available at http://www.who.int/nutrition/challenges. Accessed October 2008

  4. Fagule D (1990) Malnutrition: a reappraisal of the major predisposing factors. Niger J Paediatr 17:7–13

    Google Scholar 

  5. Schaible U, Kaufmann SHE (2007) Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 4:e115

    Article  PubMed  Google Scholar 

  6. World Health Organization (2000) Management of the child with serious infection or severe malnutrition. Geneva: WHO/FCH/CAH/00.1. Available at http://www.helid.desastres.net/gsdl2/tmp/export/who/who89e.pdf. Accessed October 2008

  7. Krishnaswamy K (1989) Drug metabolism and pharmacokinetics in malnourished children. Clin Pharmacokinet 17:68–88

    Article  PubMed  Google Scholar 

  8. Wellcome Trust Working Party (1970) Classification of infantile malnutrition. Lancet 2:302–303

    Google Scholar 

  9. Gomez F, Galvan RR, Frenk S, Munoz JC, Chavez R, Vazquez J (1956) Mortality in second and third degree malnutrition. J Trop Pediatr 2:77–83

    Google Scholar 

  10. Akbani Y, Bolme P, Lindblad BS, Rahimtoola RJ (1977) Control of streptomycin and isoniazid in malnourished children treated for tuberculosis. Acta Paediatr Scand 66:237–240

    Article  CAS  PubMed  Google Scholar 

  11. Erikksson M, Bolme P, Habte D, Paalzow L (1988) INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status. Acta Paediatr Scand 77:890–894

    Article  Google Scholar 

  12. Buchanan N, Hansen JDL, Van der Walt LA, Robinson R, Koornhof HJ (1976) Chloramphenicol metabolism in children with PCM. Am J Clin Nutr 29:327–330

    CAS  PubMed  Google Scholar 

  13. Larea-Asseff I, Cravioto J, Santiago P, Perez-Ortiz B (1993) A new dosing regimen for metronidazole in malnourished children. Scand J Infect Dis 25:115–121

    Google Scholar 

  14. Seaton C, Ignas J, Muchohi S, Kokwaro G, Maitland K, Thomson AH (2007) Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition. J Antimicrob Chemother 59:681–689

    Article  CAS  PubMed  Google Scholar 

  15. Treluyer JM, Sultan E, Alexandre JA, Roux A, Flouvat AB, Lagardere B (1991) Pharmacokinetics of aspirin in African children: influence of nutritional status. Arch Fr Pediatr 48:337–341

    CAS  PubMed  Google Scholar 

  16. Graham SM, Bell DJ, Nyirongo S, Hartkoorn R, Ward SA, Molyneux EM (2006) Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection. Antimicrob Agents Chemother 50:407–413

    Article  CAS  PubMed  Google Scholar 

  17. Samotra K, Gupte S, Raina RK (1985) Pharmacokinetics of gentamicin in protein-energy malnutrition. Eur J Clin Pharmacol 29:255–256

    Article  CAS  PubMed  Google Scholar 

  18. Larea-Asseff I, Cravioto J, Santiago P, Perez-Ortiz B (1992) Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children. Clin Pharmacol Ther 51:42–50

    Article  Google Scholar 

  19. Bolme P, Eriksson M, Paalzow L, Stintzing G, Zerihun G, Woldemariam T (1995) Malnutrition and pharmacokinetics of penicillin in Ethiopian children. Pharmacol Toxicol 76:259–262

    Article  CAS  PubMed  Google Scholar 

  20. Bano G, Sharma DB, Raina RK (1985) Pharmacokinetics of phenytoin in protein energy malnutrition. Indian J Pharmacol 17:77–78

    Google Scholar 

  21. Treluyer JM, Roux A, Mugnier C, Flouvat B, Largadere B (1996) Metabolism of quinine in children with global malnutrition. Pediatr Res 40:558–563

    Article  CAS  PubMed  Google Scholar 

  22. Kumar L, Garg SK, Singh S, Lal R, Shukla VK (1989) Theophylline pharmacokinetics in well-nourished and malnourished asthmatic children. Int J Clin Pharmacol Ther Toxicol 27:588–592

    CAS  PubMed  Google Scholar 

  23. Buchanan N, Eyberg C (1978) Intramuscular tobramycin administration in kwashiorkor. S Afr Med J 53:273–274

    CAS  PubMed  Google Scholar 

  24. Bano G, Raina RK, Sharma DB (1986) Pharmacokinetics of carbamazepine in protein energy malnutrition. Pharmacology 32:232–236

    Article  CAS  PubMed  Google Scholar 

  25. Walker O, Dawodu AH, Salako LA, Alvan G, Johnson AOK (1987) Single disposition of chloroquine in kwashiorkor and normal children—evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol 23:467–472

    CAS  PubMed  Google Scholar 

  26. Akinyinka OO, Sowunmi A, Honeywell R, Renwick AG (2000) The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor. Eur J Clin Pharmacol 56:153–158

    Article  CAS  PubMed  Google Scholar 

  27. Mehta S, Kalsi HK, Jayaraman S, Mathur VS (1975) Chloramphenicol metabolism in children with protein-calorie malnutrition. Am J Clin Nutr 28:977–981

    CAS  PubMed  Google Scholar 

  28. Mehta S, Nain CK, Yadav D, Sharma B, Mathur VS (1985) Disposition of acetaminophen in children with protein calorie malnutrition. Int J Clin Pharmacol Ther Toxicol 23:311–315

    CAS  PubMed  Google Scholar 

  29. Syed GB, Sharma DB, Raina RK (1986) Pharmacokinetics of phenobarbitone in protein energy malnutrition. Dev Pharmacol Ther 9:317–322

    CAS  PubMed  Google Scholar 

  30. Salako LA, Sowunmi A, Akinbami FO (1989) Pharmacokinetics of quinine in African children suffering from kwashiorkor. Br J Clin Pharmacol 28:197–201

    CAS  PubMed  Google Scholar 

  31. Mehta S, Nain CK, Sharma B, Mathur VS (1980) Metabolism of sulfadiazine in children with protein calorie malnutrition. Pharmacology 21:369–374

    Article  CAS  PubMed  Google Scholar 

  32. Bravo IG, Bravo ME, Plate G, Merlez J, Arancibia A (1984) The pharmacokinetics of cotrimoxazole sulphonamide in malnourished (Marasmic) infants. Pediatr Pharmacol (New York) 4:167–176

    CAS  Google Scholar 

  33. Eriksson M, Paalzow L, Bolme P, Mariam TW (1983) Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status. Eur J Clin Pharmacol 24:819–823

    Article  CAS  PubMed  Google Scholar 

  34. Buchanan N, Van der Walt LA (1997) Chloramphenicol binding to normal and kwashiorkor sera. Am J Clin Nutr 30:847–850

    Google Scholar 

  35. Buchanan N (1977) Drug-protein binding and protein energy malnutrition. S Afr Med J 52:733–737

    CAS  PubMed  Google Scholar 

  36. Buchanan N, Van der Walt LA, Strickwold B (1976) Pharmacology of malnutrition. III. Binding of digoxin to normal and kwashiorkor serum. J Pharm Sci 65:914–916

    Article  CAS  PubMed  Google Scholar 

  37. Buchanan N, Van der Walt LA (1977) The binding of antituberculous drugs to normal and kwashiorkor serum. S Afr Med J 52:522–525

    CAS  PubMed  Google Scholar 

  38. Eyberg C, Moodley GP, Buchanan N (1974) The pharmacology of malnutrition. I. Salicylate binding studies using normal/plasma kwashiorkor serum. S Afr Med J 48:2564–2577

    CAS  PubMed  Google Scholar 

  39. Buchanan N, Van der Walt LA (1977) The binding of thiopentone to kwashiorkor serum. Br J Anaesth 49:247–250

    Article  CAS  PubMed  Google Scholar 

  40. Buchanan N, Van der Walt LA (1977) The binding of chloroquine to normal and kwashiorkor serum. Am J Trop Med Hyg 26:1025–1027

    CAS  PubMed  Google Scholar 

  41. Buchanan N, Davis MD, Henderson DB, Mucklow JC, Rawlins MD (1980) Acetanilide pharmacokinetics in kwashiorkor. Br J Clin Pharmacol 9:525–526

    CAS  PubMed  Google Scholar 

  42. Hendricks MK, Van der Bijl P, Parkin DP, Donald PR (1995) Pharmacokinetics of amikacin in children with kwashiorkor. Ann Trop Paediatr 15:295–298

    CAS  PubMed  Google Scholar 

  43. Narang RK, Mehta S, Mathur VS (1977) Pharmacokinetic study of antipyrine in malnourished children. Am J Clin Nutr 30:1979–1982

    CAS  PubMed  Google Scholar 

  44. Buchanan N, Eyberg C, Davis MD (1979) Antipyrine pharmacokinetics and D-glutaric excretion in kwashiorkor. Am J Clin Nutr 32:2439–2442

    CAS  PubMed  Google Scholar 

  45. Homeida M, Karrar ZA, Roberts CJC (1979) Drug metabolism in malnourished children: a study with antipyrine. Arch Dis Child 54:299–302

    Article  CAS  PubMed  Google Scholar 

  46. Buchanan N, Eyberg C, Davis MD (1979) Isoniazid pharmacokinetics in kwashiorkor. S Afr Med J 56:299–300

    CAS  PubMed  Google Scholar 

  47. Buchanan N, Robinson P, Koornhof HJ, Eyberg C (1979) Penicillin pharmacokinetics in kwashiorkor. Am J Clin Nutr 32:2233–2236

    CAS  PubMed  Google Scholar 

  48. Bolme P, Eriksson M, Habte D, Paalzow L (1988) Pharmacokinetics of streptomycin in Ethiopian children with tuberculosis and different nutritional status. Eur J Clin Pharmacol 33:647–649

    Article  CAS  PubMed  Google Scholar 

  49. Eriksson M, Paalzow L, Bolme P, Mariam TW (1983) Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status. Eur J Clin Pharmacol 24:89–92

    Article  CAS  PubMed  Google Scholar 

  50. Bravo ME, Arancibia A, Jarpa S, Carpentier PM, Jahn AN (1982) Pharmacokinetics of gentamicin in malnourished infants. Eur J Clin Pharmacol 21:499–504

    Article  CAS  PubMed  Google Scholar 

  51. Pussard E, Barennes H, Daouda H, Clavier F, Sani AM, Osse M, Granic G, Verdier F (1999) Quinine disposition in globally malnourished children with cerebral malaria. Clin Pharmacol Ther 65:500–510

    Article  CAS  PubMed  Google Scholar 

  52. Buchanan N, Davis MD, Eyberg C (1979) Gentamicin pharmacokinetics in kwashiorkor. Br J Clin Pharmacol 8:451–453

    CAS  PubMed  Google Scholar 

  53. Buchanan N, Mithal Y, Witcomb M (1980) Cefoxitin: intravenous pharmacokinetics and intramuscular bioavailability in kwashiorkor. Br J Clin Pharmacol 9:623–627

    CAS  PubMed  Google Scholar 

  54. Mehta S, Nain CK, Sharma B, Mathur VS (1982) Disposition of four drugs in malnourished children. Drug Nutr Interact 1:205–211

    CAS  PubMed  Google Scholar 

  55. Seifart HI, Donald PR, De Villiers JN, Parkin DP, Jaarsveld PP (1995) Isoniazid elimination kinetics in children with protein-energy malnutrition treated for tuberculous meningitis with a four-component antimicrobial regimen. Ann Trop Paediatr 15:249–254

    CAS  PubMed  Google Scholar 

  56. Cohen-Kohler JC (2007) The morally uncomfortable global drug gap. Clin Pharmacol Ther 82:610–614

    Article  CAS  PubMed  Google Scholar 

  57. De Onis M, Frongillo EA, Blössner M (2000) Is malnutrition declining? An analysis of changes in levels of child malnutrition since 1980. Bull World Health Organ 78:1222–1233

    PubMed  Google Scholar 

  58. Khor GL (2003) Update on the prevalence of malnutrition among children in Asia. Nepal Med Coll J 5:113–122

    PubMed  Google Scholar 

  59. Trouiller P, Olliaro P, Torreele E, Orbinski J et al (2002) Drug development for neglected diseases: a deficient market and public-health policy failure. Lancet 359:2188–2194

    Article  PubMed  Google Scholar 

  60. Clark J (2003) Euro MPs vote on research fund for neglected diseases. Br Med J 326:680

    Article  Google Scholar 

  61. Faull R, Lee L (2007) Prescribing in renal disease. Aust Prescr 30:17–20

    Google Scholar 

  62. Mutabingwa TK (2005) Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop 95:305–315

    Article  CAS  PubMed  Google Scholar 

  63. World Health Organization (2006) Guidelines for the treatment of malaria. WHO. Available at: http://apps.who.int/malaria/docs/TreatmentGuidelines2006.pdf. Accessed November 2009

  64. Projean D, Baune B, Farinotti R, Flinois J, Beaune P, Taburet A, Ducharme J (2003) In-vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Disp 31:748–754

    Article  CAS  Google Scholar 

  65. German PI, Aweeka FT (2008) Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet 47:91–102

    Article  PubMed  Google Scholar 

  66. Rylance G (1981) Drugs in children. BMJ 282:50–51

    Article  CAS  PubMed  Google Scholar 

  67. Churchwell MD, Pasko DA, Smoyer WE, Mueller BA (2009) Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modelled continuous hemodialysis. Nephrol Dial Transplant 24:231–238

    Article  CAS  PubMed  Google Scholar 

  68. Thomson AH (2006) Population pharmacokinetics and pharmacodynamics. In: Jacqz-Aigrain E, Choonara I (eds) Paediatric clinical pharmacology, 1st edn. Fontis Media S.A./Taylor & Francis Group, London/New York, pp 147–159

    Google Scholar 

  69. Parker AC, Pritchard P, Preston T, Smyth RL et al (1997) Enhanced drug metabolism in young children with cystic fibrosis. Arch Dis Child 77:239–241

    Article  CAS  PubMed  Google Scholar 

  70. Pons G, Blais JC, Rey E, Plissonnier M et al (1988) Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test. Pediatr Res 11:258–264

    CAS  Google Scholar 

  71. Choonara I (2009) Children’s medicines—a global problem. Arch Dis Child 94:467

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

KAO is a postgraduate research student being jointly sponsored by the Lagos State Government and the Lagos State University, Ojo, Lagos, Nigeria. The authors acknowledge these sponsoring bodies.

Author information

Authors and Affiliations

  1. Academic Division of Child Health, The Medical School in Derby, Royal Derby Hospital, University of Nottingham, Uttoxeter Road, Derby, DE 22 3DT, UK

    Kazeem A. Oshikoya, Helen M. Sammons & Imti Choonara

Authors
  1. Kazeem A. Oshikoya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen M. Sammons
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Imti Choonara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazeem A. Oshikoya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oshikoya, K.A., Sammons, H.M. & Choonara, I. A systematic review of pharmacokinetics studies in children with protein-energy malnutrition. Eur J Clin Pharmacol 66, 1025–1035 (2010). https://doi.org/10.1007/s00228-010-0851-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0851-0

Keywords

Search

Navigation